Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Barry D. Liboiron"'
Autor:
Robert K. Stuart, Arthur C. Louie, Timothy Callahan, Lawrence D. Mayer, Kamalika Banerjee, Eric Rubenstein, Barry D. Liboiron, Donna Alvarez, Laura C. Michaelis, Laura F. Newell, Qi Wang, Tara L. Lin, Helen S. Pentikis
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose Daunorubicin can induce left ventricular dysfunction and QT interval prolongation. This study assessed the effects of CPX-351, a liposomal encapsulation of cytarabine and daunorubicin, on cardiac repolarization. Methods Twenty-six adults with
Autor:
Lawrence D. Mayer, Barry D. Liboiron
Publikováno v:
Therapeutic Delivery. 5:149-171
While combination chemotherapy has led to measurable improvements in cancer treatment outcomes, its full potential remains to be realized. Nanoscale particles such as liposomes, nanoparticles and polymer micelles have been shown to increase delivery
Autor:
Paul Tardi, Sherwin Xie, Barry D. Liboiron, Troy Harasym, Peng Zou, Lawrence D. Mayer, Stephan T. Stern, Sarah L. Skoczen, Scott E. McNeil
Publikováno v:
Journal of Controlled Release. 172:558-567
Pharmacokinetic modeling and simulation is a powerful tool for the prediction of drug concentrations in the absence of analytical techniques that allow for direct quantification. The present study applied this modeling approach to determine active dr
Publikováno v:
Molecular Physics. 111:2967-2979
We describe a 1D and 2D electron spin echo envelope modulation investigation of VO2+ adsorbed on hydroxyapatite (HA) at different concentrations and compare with VO2+–triphosphate (TPH) complexes studied previously in detail, in an effort to provid
Publikováno v:
Drug Delivery in Oncology: From Basic Research to Cancer Therapy
Autor:
Paul Tardi, Lawrence D. Mayer, Xiaowei Xie, Troy Harasym, David Bermudes, Wahseng Lim, Barry D. Liboiron, Xiaoping Huang, Mannie Fan, Nancy Dos Santos
Publikováno v:
Leukemia Research. 34:1214-1223
The objective of this study was to examine the pharmacodynamic basis for the potent preclinical and clinical anti-leukemic activity of CPX-351, a nano-scale liposome formulation of cytarabine and daunorubicin co-encapsulated at a synergistic 5:1 mola
Publikováno v:
International Journal of Pharmaceutics. 391:248-259
The biophysical characterization of CPX-351, a liposomal formulation of cytarabine and daunorubicin encapsulated in a synergistic 5:1 molar ratio (respectively), is presented. CPX-351 is a promising drug candidate currently in two concurrent Phase 2
Autor:
Anne Hinderliter, Thomas C. Weber, Connie Cho, April A. Frazier, Awa Dicko, Xiaowei Xie, Lawrence D. Mayer, David S. Cafiso, Jeff F. Ellena, Paul Tardi, Donna Cabral-Lilly, Barry D. Liboiron
Publikováno v:
Pharmaceutical Research. 25:1702-1713
The inter/intramolecular interactions between drugs (floxuridine, irinotecan) and excipients (copper gluconate, triethanolamine) in the dual-drug liposomal formulation CPX-1 were elucidated in order to identify the physicochemical properties that all
Autor:
Chris Orvig, Barry D. Liboiron, Nicolas Aebischer, Katherine H. Thompson, Edmond Lam, Graeme R. Hanson
Publikováno v:
Journal of the American Chemical Society. 127:5104-5115
Significant new insights into the interactions of the potent insulin-enhancing compound bis(maltolato)oxovanadium(IV) (BMOV) with the serum proteins, apo-transferrin and albumin, are presented. Identical reaction products are observed by electron par
Autor:
Sergei A. Dikanov, Barry D. Liboiron, Katherine H. Thompson, Violet G. Yuen, E. Vera, John H. McNeill, Chris Orvig
Publikováno v:
Bioinorganic Chemistry and Applications
The biological fate of a chelated vanadium source is investigated by/n vivo spectroscopic methods to elucidate the chemical form in which the metal ion is accumulated. A pulsed electron paramagnetic resonance study of vanadyl ions in kidney tissue, t